These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1283098)

  • 21. Diabetes-related renal growth and IGF-I accumulation in castrated rats.
    Bach LA; Cox AJ; Jerums G
    Diabetes Res Clin Pract; 1991 Oct; 14(1):15-20. PubMed ID: 1748060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JB3, an IGF-I receptor antagonist, inhibits early renal growth in diabetic and uninephrectomized rats.
    Haylor J; Hickling H; El Eter E; Moir A; Oldroyd S; Hardisty C; El Nahas AM
    J Am Soc Nephrol; 2000 Nov; 11(11):2027-2035. PubMed ID: 11053478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of insulin-like growth factors in diabetic kidney disease.
    LeRoith D; Werner H; Phillip M; Roberts CT
    Am J Kidney Dis; 1993 Nov; 22(5):722-6. PubMed ID: 8238020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation.
    Langford KS; Miell JP
    Eur J Clin Invest; 1993 Sep; 23(9):503-16. PubMed ID: 7694853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renal growth hormone/insulin-like growth factor I axis.
    Hammerman MR
    Am J Kidney Dis; 1991 Jun; 17(6):644-6. PubMed ID: 2042640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between insulin-like growth factor-I and -II and IGF-binding proteins in milk and the gastrointestinal tract: growth and development of the gut.
    Zumkeller W
    J Pediatr Gastroenterol Nutr; 1992 Nov; 15(4):357-69. PubMed ID: 1281875
    [No Abstract]   [Full Text] [Related]  

  • 27. [Insulin-like growth factor I in diabetes].
    Morimoto I; Kai K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():112-6. PubMed ID: 9513399
    [No Abstract]   [Full Text] [Related]  

  • 28. [Insulin-like growth factor I (somatomedin-C)].
    Morimoto I
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():446-50. PubMed ID: 12355788
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease.
    Ren J; Samson WK; Sowers JR
    J Mol Cell Cardiol; 1999 Nov; 31(11):2049-61. PubMed ID: 10591031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-binding protein-1: a role in glucose counterregulation?
    Lewitt MS; Baxter RC
    Mol Cell Endocrinol; 1991 Aug; 79(1-3):C147-52. PubMed ID: 1718795
    [No Abstract]   [Full Text] [Related]  

  • 31. IGF/IGFR and diabetes mellitus in head and neck squamous cell carcinoma patients.
    Mastronikolis NS; Rigopoulos DN; Tsiambas E; Ragos V
    J BUON; 2017; 22(5):1361-1362. PubMed ID: 29135128
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.
    Preston RA; Epstein M
    Diabetes Care; 1999 Jun; 22(6):982-8. PubMed ID: 10372252
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between kidney size and function in short-term diabetic patients.
    Christiansen JS; Parving HH
    Diabetologia; 1982 Jun; 22(6):494. PubMed ID: 7106447
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the pathogenesis and clinic of diabetic nephropathy].
    MUTING D
    Ann Univ Sarav Med; 1958; 6(3-4):322-3. PubMed ID: 13637525
    [No Abstract]   [Full Text] [Related]  

  • 35. Perspectives in physiology: cell growth.
    Spitzer A
    Pediatr Nephrol; 1987 Apr; 1(2):230-7. PubMed ID: 3153282
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelets disrupt vasculogenic mimicry by cancer cells.
    Martini C; Thompson EJ; Hyslop SR; Cockshell MP; Dale BJ; Ebert LM; Woods AE; Josefsson EC; Bonder CS
    Sci Rep; 2020 Apr; 10(1):5869. PubMed ID: 32246008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.
    Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF
    Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
    Lambertini M; Campbell C; Gelber RD; Viale G; McCullough A; Hilbers F; Korde LA; Werner O; Chumsri S; Jackisch C; Wolff AC; Vaz-Luis I; Ferreira AR; Prat A; Moreno-Aspitia A; Piccart M; Loi S; de Azambuja E
    Breast Cancer Res Treat; 2019 Aug; 177(1):103-114. PubMed ID: 31134488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of secreted protein acidic and rich in cysteine with diabetic nephropathy.
    Li L; Song HY; Liu K; An MM
    Int J Clin Exp Med; 2015; 8(8):12746-55. PubMed ID: 26550188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.
    Vasylyeva TL; Ferry RJ
    Diabetes Res Clin Pract; 2007 May; 76(2):177-86. PubMed ID: 17011663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.